List of Studies ( Metabolite:5-Hydroxylysine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | Abundances | |
ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
ST001639 | AN002681 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
ST001855 | AN003006 | The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 1) | Kidney | Mouse | Kidney disease | Children’s Hospital of Nanjing Medical University | AUC |
ST001856 | AN003008 | The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 2) | Kidney | Mouse | Kidney disease | Children's Hospital of Nanjing Medical University | AUC |
ST002287 | AN003739 | Enhanced systemic commensal E. coli immunogenicity through minor alteration of the metabolic profile | Bacterial cells | E. coli | University of Calgary | AUC | |
ST002289 | AN003741 | Map of microbially induced metabolic changes across diverse body sites in mice - Bacterial culture data | Bacterial cells | Bacteria | University of Calgary | AUC | |
ST002457 | AN004009 | Mouse kidney metabolomics (Whole kidney) | Kidney | Mouse | Chronic kidney disease | Hadassah Medical Center | concentration |
ST000946 | AN001553 | Untargeted Metabolomics of T1 Participants | Blood | Human | Environmental exposure | University of Michigan | Counts |
ST001688 | AN002756 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) | Bacterial cells | Bacteria | Stanford University | Counts | |
ST001671 | AN002727 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism | Bacterial cells | Bacteria | Stanford University | counts (area) | |
ST001671 | AN002729 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism | Bacterial cells | Bacteria | Stanford University | counts (area) | |
ST001688 | AN002758 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) | Bacterial cells | Bacteria | Stanford University | counts (area) | |
ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | estimated abundances | |
ST001179 | AN001956 | Metabolomic analysis of skeletal muscle in young and aged mice | Muscle | Mouse | Sarcopenia | Kyoto Prefectural University | fold |
ST002555 | AN004207 | Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures | Cultured cells | Human | Cancer | University of Oklahoma Health Sciences Center | Fold change over standard |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST002149 | AN003519 | In vivo commensal control of Clostridioides difficile virulence | Cecum | Mouse | Brigham and Women’s Hospital | Intensity | |
ST001775 | AN002882 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Blood | Mouse | Malaria | Stanford University | ion counts |
ST002829 | AN004619 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | log transformed data |
ST001933 | AN003143 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Blood | Human | COVID-19 | Hong Kong Baptist University | µM |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001884 | AN003048 | Metabolomics of Ndufs4 KO urine (part - II) | Urine | Mouse | Leigh syndrome | North-West University | mg/g creatinine |
ST002579 | AN004250 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Targeted Amines | Blood | Rat | Mayo Clinic | Micromolar | |
ST001690 | AN002760 | Untargeted metabolomic analysis of human blood samples via qualitative GC-MS for T1D biomarker identification | Blood | Human | Diabetes | Duke University | minutes |
ST002212 | AN003616 | Human fecal metabolome profiles under 3 different dietary terms | Feces | Human | Keio University | µmol/g | |
ST002598 | AN004270 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Targeted Amines | Heart | Rat | Mayo Clinic | nano moles per vial | |
ST002604 | AN004276 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Targeted Amines | Kidney | Rat | Mayo Clinic | nano moles per vial | |
ST002608 | AN004280 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Lung Powder - Targeted Amines | Lung | Rat | Mayo Clinic | nano moles per vial | |
ST002622 | AN004294 | MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Targeted Amines | White adipose | Rat | Mayo Clinic | nano moles per vial | |
ST000570 | AN000878 | Metabolome analysis of the cecal contents of GF mice and GF mice colonized with dominant gut microbes present in the ceca of neonatal and adult mice | Feces | Mouse | Keio University | nmol/g | |
ST001250 | AN002075 | Luminal metabolome profiles of mice developed dextran sulfate sodium (DSS) colitis | Feces | Mouse | Colitis | University of Michigan | nmol/g |
ST001300 | AN002164 | Luminal metabolome profiles ofUC-HMA mice transplanted with a healthy human-derived fecal microbiota (FMT). | Feces | Mouse | Bacterial infection | University of Michigan | nmol/g |
ST001301 | AN002166 | Luminal metabolome profiles of human microbiota-associated (HMA) mice treated with anti-IL-22 antibody or control antibody | Feces | Mouse | Bacterial infection | University of Michigan | nmol/g |
ST002170 | AN003555 | Cecal metabolome of specific-pathogen-free mice fed with five distinct rodent diets with varying fiber content and source. | Cecum | Mouse | Luxembourg Institute of Health | nmol/g | |
ST002172 | AN003559 | Cecal metabolome of gnotobiotic (containing a 14-member synthetic human gut microbiota), and germ-free mice fed with two distinct rodent diets with varying fiber content. | Cecum | Mouse | Luxembourg Institute of Health | nmol/g | |
ST002476 | AN004077 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Mouse) | Intestine | Mouse | COVID-19 | Keio University | nmol/g |
ST002476 | AN004077 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Mouse) | Intestine | Mouse | Influenza | Keio University | nmol/g |
ST002479 | AN004079 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Hamster) | Intestine | Mouse | COVID-19 | Keio University | nmol/g |
ST002479 | AN004079 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Hamster) | Intestine | Mouse | Influenza | Keio University | nmol/g |
ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Blood | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Liver | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
ST002028 | AN003298 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Feces | Human | UC Davis | normalized peak height | |
ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | osmolality normalized scaled imputed | |
ST002153 | AN003526 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Blood | Mouse | Morinaga milk industry CO., LTD. | peak area | |
ST002431 | AN003957 | MS profiling of the Long Term Evolution Experiment | Bacterial cells | E. coli | Rutgers University | peak area | |
ST002498 | AN004654 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST002536 | AN004171 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | peak area |
ST000016 | AN000033 | NPM-ALK metabolic regulation | Lymphoma cells | Human | University of Michigan | Peak area | |
ST000164 | AN000256 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Bone marrow | Mouse | Diabetes | New York University | Peak area |
ST000230 | AN000344 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Liver | Human | Cancer | Osaka City University | Peak area |
ST000231 | AN000346 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (part II) | Liver | Human | Cancer | Osaka City University | Peak area |
ST001004 | AN001714 | Denver Asthma Panel Study-CHEAR Ancillary Study | Blood | Human | Asthma | Emory University | Peak area |
ST001157 | AN001915 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Blood | Mouse | Johns Hopkins University School of Medicine | Peak area | |
ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University School of Medicine | Peak area | |
ST001193 | AN001988 | MARBLES (Markers of Autism Risk in Babies: Learning Early Sign) Enriched Cohort Study: Internal Metabolomic Biomarker Exposome and Development Disorders (IMBEDD) | Blood | Human | Autism | Emory University | Peak area |
ST001209 | AN002012 | MARBLES (Markers of Autism Risk in Babies: Learning Early Sign) Enriched Cohort Study:Internal Metabolomic Biomarker Exposome and Development Disorders (IMBEDD) | Blood | Human | Autism | Emory University | Peak area |
ST001212 | AN002045 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen | Peak area | |
ST001218 | AN002031 | Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet | Kidney | Mouse | Cancer | weill cornell medicine | Peak area |
ST001385 | AN002313 | Urine Metabolomics | Urine | Human | Icahn School of Medicine at Mount Sinai | Peak area | |
ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | Peak area |
ST002492 | AN004081 | Composition of raw plant-based food items | Plant | Plants | Northeastern University | Peak area | |
ST002909 | AN004775 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak area |
ST002292 | AN003744 | Quantification of Dissolved Metabolites in Environmental Samples through Cation-Exchange Solid Phase Extraction (CX-SPE) paired with Liquid Chromatography-Mass Spectrometry | Water | Other | University of Washington | Peak Area | |
ST002754 | AN004468 | Metabolomics analysis of maternal obesity model | Blood | Mouse | Fatty liver disease | University of Bonn | Peak Area |
ST000586 | AN000901 | Evaluation of specific concentrations for use in experimental protocol | Blood | Human | Duke University | Peak area (Log2 transformed) | |
ST000589 | AN000904 | Effects of dilution on analyte identification and quantification | Blood | Human | Duke University | Peak area (Log2 transformed) | |
ST000552 | AN000843 | Metabolite signatures in trauma patients with venous thromboembolism (VTE) | Blood | Human | Trauma | University of Florida | Peak height |
ST000555 | AN000851 | Cocaine administration and withdrawal (part II) | Brain | Rat | Drug addiction | University of Florida | Peak height |
ST000953 | AN001562 | Identification of putative cryoprotectant metabolites in Aphaenogaster picea | Whole Tissue | Ant | Stress | University of Florida | Peak height |
ST000956 | AN001568 | Determine metabolomics signatures important for the ability of Streptococus gallolyticus to promote colon cancer cell proliferation | Cultured cells | Human | Cancer | University of Florida | Peak height |
ST001928 | AN003136 | Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype | Urine | Human | George Mason University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | Peak height | |
ST001754 | AN002857 | Metabolomic Analysis of Canine Diabetes (part-II) | Blood | Dog | Diabetes | University of Florida | Peak Height |
ST001754 | AN002858 | Metabolomic Analysis of Canine Diabetes (part-II) | Blood | Dog | Diabetes | University of Florida | Peak Height |
ST002407 | AN003924 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract | Intestine | Human | UC Davis | Peak Height | |
ST001154 | AN001945 | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | Blood | Mouse | University of California | Peak height normalized with creatinine | |
ST000355 | AN000581 | GC/MS and LC/MS metabolomics profiling for breast cancer plasma data and control plasma data | Blood | Human | Cancer | University of Hawaii Cancer Center | Peak intensity |
ST000356 | AN000583 | GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data | Blood | Human | Cancer | University of Hawaii Cancer Center | Peak intensity |
ST001048 | AN001716 | Pediatric Inner-City Environmental Exposures at School and Home and Asthma Study | Urine | Human | Asthma | Icahn School of Medicine at Mount Sinai | Peak intensity |
ST000349 | AN000565 | Metabolomic analysis on samples from rats expressing human amylin (hepatic tissue). | Liver | Rat | Diabetes | University of North Carolina | Peak values (Log transformed) |
ST000350 | AN000566 | Metabolomic analysis on samples from rats expressing human amylin (plasma). | Blood | Rat | Diabetes | University of North Carolina | Peak values (Log transformed) |
ST000894 | AN001456 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Liver Metabolism In Vivo | Liver | Mouse | Cancer | University of North Carolina | Peak values (Log transformed) |
ST000895 | AN001457 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis | Blood | Mouse | Cancer | University of North Carolina | Peak values (Log transformed) |
ST000925 | AN001518 | MuRF1-Related Metabolomic Changes in Stretched and Unloaded HL-1 Cells | Cardiomyocyte cells | Mouse | University of North Carolina | Peak values (Log transformed) | |
ST000451 | AN000707 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Muscle | Mouse | University of North Carolina | Peak values (scaled) | |
ST000452 | AN000708 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Blood | Mouse | University of North Carolina | Peak values (scaled) | |
ST000645 | AN000977 | Effects of Exercise on Dystrophic Mouse Muscle Amino Acids (part II) | Heart | Mouse | Muscular dystrophy | Mayo Clinic | picomol/mg |
ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
ST000511 | AN000784 | Determine how inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect amino acid metabolites | Muscle | Mouse | Diabetes | Mayo Clinic | pmol/mg |
ST000648 | AN000980 | Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Amino Acids (part IV) | Heart | Mouse | Muscular dystrophy | Mayo Clinic | pmol/mg |
ST001983 | AN003234 | Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines | Ovarian cancer cells | Human | Cancer | University of Oklahoma Health Sciences Center | ratio |
ST000899 | AN001462 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
ST001400 | AN002340 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001516 | AN002515 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001517 | AN002518 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001749 | AN002848 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
ST002818 | AN004586 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002819 | AN004590 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002090 | AN003414 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) | Feces | Mouse | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Blood | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Feces | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Intestine | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002747 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Urine | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Blood | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Feces | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Intestine | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Urine | Mouse | Stanford University | Raw ion count (peak area) | |
ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST002082 | AN003398 | Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer | Urine | Human | Cancer | University of Liverpool Institute of Life Course & Medical Sciences | raw peak area |
ST002082 | AN003399 | Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer | Urine | Human | Cancer | University of Liverpool Institute of Life Course & Medical Sciences | raw peak area |
ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | Relative Abundance | |
ST002206 | AN003609 | Lipolysis-derived Lipids Determine Autophagy Initiation during Fasting | Worms | C. elegans | Seoul National University | relative area | |
ST001439 | AN002403 | Metabolites in contents of small intestine in wild type and DAOG181R/G181R mice | Intestine | Mouse | KEIO University School of Medicine | relative_area | |
ST000384 | AN000619 | Metabolomic profiles in P. gingivalis cells treated with pABA | Bacterial cells | Porphyromonas | Osaka University Graduate School of Dentistry | Relative Area | |
ST001668 | AN002720 | D-Allulose effects on hepatic metabolomics profile in rodents | Liver | Rat | Matsutani Chemical Industry Co., Ltd. | Relative Area | |
ST002584 | AN004256 | Metabolomics analysis of ALDH1L1-expressing HuH7 cell lines. | Cultured cells | Human | Cancer | Tohoku Medical and Pharmaceutical University | Relative Area |
ST002512 | AN004137 | Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta | Intestine | Mouse | University of California, San Francisco | relative ion counts | |
ST002088 | AN003406 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002089 | AN003410 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST001869 | AN003031 | WNK463 Inhibition on Right Ventricular metabolomics | Heart | Rat | Hypertension | University of Minnesota | relative value |
ST001870 | AN003032 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Heart | Rat | University of Minnesota | relative value | |
ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST000930 | AN001524 | Define alterations in the gut metabolome of mice infected with C. difficile | Intestine | Mouse | North Carolina State University | scaled intensity | |
ST001968 | AN003206 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/plasma | Blood | Goat | INSERM | SI | |
ST001968 | AN003208 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/plasma | Blood | Goat | INSERM | SI | |
ST001970 | AN003213 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:MS/milk | Milk | Goat | INSERM | SI | |
ST002231 | AN003640 | Metabolomics Analysis of HOG-EV and HOG-R132H Cells with and without BAY 2402234 Treatment | Cultured cells | Human | Cancer | UT Southwestern Medical Center | TIC-Corrected Peak Area |
ST000149 | AN000236 | High Insulin Combined With Essential Amino Acids Stimulates Skeletal Muscle Mitochondrial Protein Synthesis While Decreasing Insulin Sensitivity in Healthy Humans | Muscle | Human | Diabetes | Mayo Clinic | uM |
ST000168 | AN000262 | Effect of Insulin Sensitizer Therapy on Amino Acids and Their Metabolites | Blood | Human | Diabetes | Mayo Clinic | uM |
ST000435 | AN000685 | Quantitative measurements of amino acids in T1D poor control, good control, and controls. | Blood | Human | Diabetes | Mayo Clinic | uM |
ST000483 | AN000749 | Amino Acid Quantifcation of obese patients on a 16 week caloric restriction from Plasma | Blood | Human | Obesity | Mayo Clinic | uM |
ST000491 | AN000757 | Sleep apnea and cardiovascular samples amino acid metabolites | Blood | Human | Sleep apnea | Mayo Clinic | uM |
ST000514 | AN000787 | Inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect amino acids metabolites in serum | Muscle | Mouse | Diabetes | Mayo Clinic | uM |
ST000524 | AN000802 | Effects of Curcumin Supplementation on the Amino Acid Concentration of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | uM |
ST000629 | AN000961 | Amino Acd Metabolites of Dietary Salt Effects on Blood Pressure in Human Urine from 20 Participants of the DASH2 Clinical Trial (part II) | Urine | Human | Heart disease | Mayo Clinic | uM |
ST000632 | AN000964 | Amino Acid Metabolites of Dietary Salt Effects on Blood Pressure in Rat Urine (part V) | Urine | Rat | Heart disease | Mayo Clinic | uM |
ST000635 | AN000967 | Amino Acid Metabolites of Dietary Salt Effects on Blood Pressure in Human Urine from DASH2 Clinical Trial (part VIII) | Urine | Human | Heart disease | Mayo Clinic | uM |
ST000641 | AN000973 | Targeted Amino Acids in American Indian Adolescents (part II) | Blood | Human | Diabetes | Mayo Clinic | uM |
ST000791 | AN001259 | Identifying metabolic adaptations characteristic of multiple myeloma cells via amino acids concentrations from bone marrow plasma | Bone marrow | Human | Cancer | Mayo Clinic | uM |
ST000995 | AN001624 | Amino Acid Concentrations of Primary Sclerosing Cholangitis (part I) | Blood | Human | Mayo Clinic | uM | |
ST001012 | AN001654 | Amino Acid Concentrations in Serum for Muscle Wasting in Cancer Cachexia (part-VII) | Blood | Human | Cachexia | Mayo Clinic | uM |
ST001012 | AN001654 | Amino Acid Concentrations in Serum for Muscle Wasting in Cancer Cachexia (part-VII) | Blood | Human | Cancer | Mayo Clinic | uM |
ST001148 | AN001895 | Effect of cell harvesting technique and storage on metabolic profiles in human skin fibroblasts | Fibroblast cells | Human | Mayo Clinic | uMol/gram protein | |
ST002246 | AN003666 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | Unitless Abundances | |
ST002427 | AN003950 | Dansylated Human Plasma at Known Light-Heavy Mixing Ratios | Blood | Human | University of North Carolina Greensboro | unitless L/H ratio | |
ST001519 | AN002525 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | unitless peak areas | |
ST000638 | AN000970 | Amino Acid Metabolites of Dietary Salt Effects on Blood Pressure in Rat Urine and Kidney Tissue (part XI) | Kidney | Rat | Heart disease | Mayo Clinic | urine uM and Tissue nnol/vial |
ST002082 | AN003396 | Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer | Urine | Human | Cancer | University of Liverpool Institute of Life Course & Medical Sciences | Values are raw peak area |
ST002082 | AN003397 | Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer | Urine | Human | Cancer | University of Liverpool Institute of Life Course & Medical Sciences | Values are raw peak area |
ST001253 | AN002079 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Blood | Mouse | Diabetes | Indiana University School of Medicine | VolNormImp Area counts |